Skip to main content
Log in

Medikamentenbezogene Non-Adherence und Symptombelastungen nach Herztransplantation

Medication-related non-adherence and symptom experiences in heart transplant patients

  • Übersicht
  • Published:
Zeitschrift für Herz-,Thorax- und Gefäßchirurgie Aims and scope

Zusammenfassung

Medikamentenbezogene Non-Adherence stellt ein signifikantes Problem in der Langzeitnachsorge der Patienten nach solider Organtransplantation dar. Der Anteil der Patienten, die Schwierigkeiten bei der regelmäßigen, pünktlichen und korrekten Dosierung der Medikamente haben, muss mit etwa 20% kalkuliert werden. Non-Adherence resultiert in verkürzten Organ- und Überlebensraten sowie erhöhten Kosten für das Gesundheitssystem. Symptombelastungen stehen in direkter Beziehung zu (Non-)Adherence. Die Identifikation von Non-Adherence in neutraler, nicht bewertender Weise ist essenziell für die Initiierung effektiver Interventionen. Obwohl schon einige Adherence-verbessernde Strategien getestet wurden, ist die Evidenz unter Nutzung randomisierter Designs zwingend erweiterungsbedürftig. Nur kombinierte Strategien unter Nutzung edukativer, kognitiver, verhaltensorientierter und psychologisch-affektiver Interventionen sind im Langzeitverlauf zielführend.

Abstract

Medication-related non-adherence constitutes a significant problem in patients after solid organ transplantation in the long term. The prevalence of those experiencing difficulties with taking, timing and dosing is estimated to be 20% resulting in decreased organ and patient survival, and increased costs for the health care system. Symptom experiences are highly and directly related to (non)-adherence. Thus, the identification of non-adherence in a neutral, non-judgemental way becomes essential for the initiation of effective strategies for improving adherence. Although an array of interventions has been evaluated for their ability to improve adherence, the recent evidence using randomized, controlled trials remains weak. Combined interventions using educational, cognitive, behavioural and psychological affective strategies have been proven to be successful in the long term.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur

  1. Butler JA, Peveler RC, Roderick P et al (2004) Measuring compliance with drug regimens after renal transplantation: comparison of self-report and clinician rating with electronic monitoring. Transplantation 77:786–789

    Article  PubMed  Google Scholar 

  2. Buxton MJ (1997) Economics of transplantation in the 21st century: new scientific opportunities but greater economic problems. Transplant Proc 29:2723–2724

    Article  PubMed  CAS  Google Scholar 

  3. Cleemput I, Kestellot K, Vanrenterghem Y, DeGeest S (2004) The economic implications of non-adherence after renal transplantation. Pharmacoeconomics 22:1217–1234

    Article  PubMed  Google Scholar 

  4. De Bleser L, Matteson M, Dobbels F et al (2009) Interventions to improve medication-adherence after transplantation: a systematic review. Transpl Int 22:780–797

    Article  Google Scholar 

  5. De Geest S, Dobbels F, Fluri C et al (2005) Adherence to the therapeutic regimen in heart, lung, and heart-lung transplant recipients. J Cardiovasc Nurs 20:S88–S98

    Article  Google Scholar 

  6. De Geest S, Borgersmans L, Gemoets H et al (1995) Incidence, determinants, and consequences of subclinical noncompliance with immunosuppressive therapy in renal transplant recipients. Transplantation 59:340–347

    Google Scholar 

  7. (o A) (o J) Deutsche Gesellschaft für bürgerorientiertes Versorgungsmanagement e.V. Patientensicherheit darf vom Gesetzgeber nicht leichtfertig aufs Spiel gesetzt werden. DGbV Press Relations. Patientensicherheit darf vom Gesetzgeber nicht leichtfertig aufs Spiel gesetzt werden. http://www.pressrelations.de/ publiziert: 27.09.2010/ Zugang: 18.11.2010

  8. Dew MA, Kormos RL, Roth LH et al (1998) Early post-transplant medical compliance and mental health predict physical morbidity and mortality one to three years after heart transplantation. J Heart Lung Transplant 18:549–562

    Article  Google Scholar 

  9. Dew MA, DiMartini AF, De Vito Dabbs A et al (2007) Rates and risk factors for nonadherence to the medical regimen after adult solid organ transplantation. Transplantation 83:858–873

    Article  PubMed  Google Scholar 

  10. Dobbels F, De Geest S, Van Cleemput J et al (2004) Effect of late medication non-compliance on outcome after Heart Transplantation: a 5-year follow-up. J Heart Lung Transplant 23:1245–1251

    Article  PubMed  Google Scholar 

  11. Dobbels F, Moons P, Abraham I et al (2008) Measuring symptom experience of side-effects of immunosuppressive drugs: the modified transplant symptom occurrence and distress scale. Transpl Int 8:764–773

    Article  Google Scholar 

  12. Dodd M, Janson S, Facione N et al (2001) Advancing the science of symptom management. J Adv Nurs 33:668–676

    Article  PubMed  CAS  Google Scholar 

  13. Drent G, De Geest S, Dobbels F et al (2009) Symptom experience, non-adherence and quality of life in adult liver transplant recipients. The Netherl J Med 67:161–168

    CAS  Google Scholar 

  14. Drent G, De Geest S, Kleibeuker JH, Haagsma EB (2008) Symptom experience associated with immunosuppressive drugs after liver transplantation in adults: possible relationship with medication non-compliance? Clin Transplant 2:700–709

    Article  Google Scholar 

  15. Hathaway DK, Winsett R, Prendergast M, Subaiya I (2003) The first report from the patient outcomes registry for transplant effects on life (PORTEL): differences in side-effects and quality of life by organ type, time since transplant and immunosuppressive regimens. Clin Transplant 17:183–194

    Article  PubMed  Google Scholar 

  16. Kugler C, Fischer S, Gottlieb J et al (2007) Symptom experiences after lung transplantation: influences on adherence and quality of life. Clin Transplant 21:590–596

    Article  PubMed  Google Scholar 

  17. Kugler C, Geyer S, Gottlieb J et al (2009) Symptom experience after solid organ transplantation. J Psychosom Res 66:101–110

    Article  PubMed  Google Scholar 

  18. Loghman-Adham M (2003) Medication non-compliance in patients with chronic disease: issues in dialysis and renal transplantation. Am J Manag Care 9:155–171

    PubMed  Google Scholar 

  19. Lough ME, Lindsey AM, Shinn JA, Stotts NA (1987) Impact of symptom frequency and symptom distress on self-reported quality of life in heart transplant recipients. Heart Lung 16:193–200

    PubMed  CAS  Google Scholar 

  20. Moons P, De Geest S, Abraham I et al (1998) Symptom experience associated with maintenance immunosuppression after heart transplantation: patient’s appraisal of side effects. Heart Lung 27:315–325

    Article  PubMed  CAS  Google Scholar 

  21. Moons P, De Geest S, Versteven K et al (2001) Psychometric Properties of the Modified Transplant Symptom Occurrence and Symptom Distress Scale. J Nurs Measur 9:115–134

    CAS  Google Scholar 

  22. Moons P, Vanrenterghem Y, Van Hooff JP et al (2003) Health-related quality of life and symptom experience in tacrolimus-based regimens after renal transplantation: a multicentre study. Transpl Int 9:653–664

    Article  Google Scholar 

  23. Osterberg L, Blaschke T (2005) Adherence to medication. N Engl J Med 353:487–497

    Article  PubMed  CAS  Google Scholar 

  24. Peters TG, Spinola KN, West JC et al (2004) Differences in patient and transplant professional perceptions of immunosuppression-induced cosmetic side effects. Transplantation 78:537–543

    Article  PubMed  Google Scholar 

  25. Pinsky BW, Takemoto SK, Lentine KL et al (2009) Transplant outcomes and economic costs associated with patient noncompliance to immunosuppression. Am J Transplant 9:2597–606

    Article  PubMed  CAS  Google Scholar 

  26. Rhodes VA, Watson PM (1987) Symptom distress, the concept: past and present. Semin Oncol 3:242–247

    Article  CAS  Google Scholar 

  27. Rosenberger J, Geckova AM, Dijk JP van et al (2005) Factors modifying stress from adverse effects of immunosuppressive medication in kidney transplant recipients. Clin Transplant 19:70–76

    Article  PubMed  Google Scholar 

  28. Russell CL, Conn VS, Jantarakupt P (2006) Older adult medication compliance: an integrative review of randomized controlled trials. Am J Health Behav 30:636–650

    PubMed  Google Scholar 

  29. Sabate E (2003) Adherence to long-term therapies. Evidence for action. World Health Organization, Geneva, Switzerland

  30. Stehlik J, Edwards LB, Kucheryavaya AJ et al (2010) The Registry of the International Society for Heart and Lung Transplantation: Twenty-seventh Official Adult Heart Transplantation Report 2010. J Heart Lung Transplant 29:1089–103

    Article  PubMed  Google Scholar 

  31. Teixeira Barros C de, Cabrita J (1999) Self-report of symptom frequency and symptom distress in kidney transplant recipients. Pharmacoepidemiol Drug Saf 8:395–403

    Article  Google Scholar 

  32. Zarifan A (2006) Symptom occurrence, symptom distress, and quality of life in renal transplant recipients. Nephrol Nurs J 33:609–618

    Google Scholar 

Download references

Interessenkonflikt

Die korrespondierende Autorin gibt an, dass kein Interessenkonflikt besteht.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to C. Kugler.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kugler, C. Medikamentenbezogene Non-Adherence und Symptombelastungen nach Herztransplantation. Z Herz- Thorax- Gefäßchir 25 (Suppl 1), 20–25 (2011). https://doi.org/10.1007/s00398-011-0834-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00398-011-0834-1

Schlüsselwörter

Keywords

Navigation